Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Prepaid Assets (2016 - 2026)

Summit Therapeutics filings provide 12 years of Prepaid Assets readings, the most recent being $17.6 million for Q1 2026.

  • Quarterly Prepaid Assets rose 92.49% to $17.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $17.6 million through Mar 2026, up 92.49% year-over-year, with the annual reading at $6.5 million for FY2025, 40.98% down from the prior year.
  • Prepaid Assets hit $17.6 million in Q1 2026 for Summit Therapeutics, up from $6.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $17.6 million in Q1 2026 and bottomed at $428000.0 in Q3 2022.
  • Average Prepaid Assets over 5 years is $5.6 million, with a median of $5.3 million recorded in 2024.
  • The largest annual shift saw Prepaid Assets tumbled 94.91% in 2022 before it surged 1085.51% in 2023.
  • Summit Therapeutics' Prepaid Assets stood at $486000.0 in 2022, then skyrocketed by 439.51% to $2.6 million in 2023, then surged by 322.43% to $11.1 million in 2024, then crashed by 40.98% to $6.5 million in 2025, then soared by 168.49% to $17.6 million in 2026.
  • Per Business Quant, the three most recent readings for SMMT's Prepaid Assets are $17.6 million (Q1 2026), $6.5 million (Q4 2025), and $7.6 million (Q3 2025).